Discontinuation report asdf
| Report ID | 279017 |
| Drug Identification Number | |
| Brand name | asdf |
| Common or Proper name | asfd |
| Company Name | |
| Market Status | |
| Active Ingredient(s) | asdf |
| Strength(s) | asdf |
| Dosage form(s) | asdf |
| Route of administration | asdf |
| Packaging size | asdf |
| Anatomical Therapeutical Chemical (ATC) code | asdf |
| Anatomical Therapeutical Chemical (ATC) description | asdf |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2022-02-02 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2251 RUE LAPIERRE LASALLE, QUEBEC CANADA H8N 1B7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-03-07 | French | Compare |
| v3 | 2026-03-07 | English | Compare |
| v2 | 2026-03-07 | French | Compare |
| v1 | 2026-03-07 | English | Compare |
Showing 1 to 4 of 4